CACaption Management, LLC
Institutional investor · Portfolio as of Q1 2024
Top Holdings1,125 positions
MONDELEZ INTL INC | 1.6M | $113.7M | 1.7% | — | — | — | Decreased — |
CITIGROUP INC | 1.8M | $110.8M | 1.7% | $37.67 | +56.64% | 3 qtrssince 2023-Q3 | Unchanged 0 |
VERIZON COMMUNICATIONS INC | 2.6M | $107.2M | 1.6% | $31.00 | +13.18% | 2 qtrssince 2023-Q4 | Decreased 0 |
CITIGROUP INC | 1.7M | $106.8M | 1.6% | — | — | — | Decreased — |
CENCORA INC | 432,600 | $105.1M | 1.6% | — | — | — | Increased — |
SAREPTA THERAPEUTICS INC | 783,000 | $101.4M | 1.5% | — | — | — | Decreased — |
VERIZON COMMUNICATIONS INC | 2.4M | $100.7M | 1.5% | — | — | — | Unchanged — |
CATERPILLAR INC | 256,200 | $93.9M | 1.4% | — | — | — | Increased — |
CATERPILLAR INC | 222,800 | $81.6M | 1.2% | — | — | — | New — |
ADOBE INC | 140,000 | $70.6M | 1.1% | — | — | — | New — |
T-MOBILE US INC | 407,800 | $66.6M | 1.0% | — | — | — | Decreased — |
ENERGY TRANSFER L P | 4M | $62.7M | 1.0% | — | — | — | Increased — |
SPDR SERIES TRUST | 1.2M | $58.9M | 0.9% | — | — | — | Decreased — |
ISHARES TR | 500,000 | $57.9M | 0.9% | — | — | — | New — |
CAPRI HOLDINGS LIMITED | 1.3M | $57.8M | 0.9% | — | — | — | Increased — |
RH | 164,400 | $57.3M | 0.9% | — | — | — | Decreased — |
CYTOKINETICS INC | 803,500 | $56.3M | 0.9% | — | — | — | Decreased — |
TAPESTRY INC | 1.2M | $56.3M | 0.9% | — | — | — | Increased — |
UNITED STATES STL CORP NEW | 1.4M | $55.8M | 0.8% | — | — | — | Increased — |
SPDR SERIES TRUST | 1.1M | $55.6M | 0.8% | $38.52 | +22.30% | 3 qtrssince 2023-Q3 | Increased 41 |
Caption Management, LLC manages $6.6B across 1125 positions as of Q1 2024. Top holdings: MDLZ puts (1.7%), C (1.7%), VZ (1.6%). Fund DNA: Momentum Trader. HoldingsIntel Score: 1/5.0.
Active quarter - 186 new positions, 257 exits, 87 increased. Top move: KRE (INCREASED, conviction 41). Portfolio: $6.6B across 1125 positions.
Top holdings by portfolio weight
Portfolio allocation by GICS sector
Behavioral investing profile
Position Outcomes
Best and worst performing positions by estimated return
Top Winners
Top Losers
Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.
Similar Funds
Funds with similar investing DNA
Explore More
Accumulation Streaks
Positions with 2+ consecutive quarters of increases - persistent directional conviction.
Continue exploring
Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer
Verify source filings on SEC EDGAR